Atracurium Besylate 10-mg/mL Injection, Preserved
Download in electronic PDF format for $75
Abstract: A formulation for preparing Atracurium Besylate 10-mg/mL Injection, Preserved. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.
Related Keywords:
atracurium besylate, formulation, compounded sterile preparations, parenteral administration, skeletal muscle relaxant
Related Categories:
FORMULATIONS, PAIN MANAGEMENT, PARENTERALS, STERILE PREPARATIONS, MUSCULOSKELETAL DISORDERS, NEUROLOGY
Printer-Friendly Version
| Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Atracurium Besylate 10-mg/mL Injection, Preserved
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 322
|
Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R, Newton Gail D
|
May/Jun 2004
Pg. 181-185
|
Basics of Compounding for Cough
Allen Loyd V Jr
|
Nov/Dec 2004
Pg. 462-465
|
Physical Compatibility and Chemical Stability of Atracurium Besylate and Midazolam Hydrochloride during Intravenous Coinfusion
Bhatt-Mehta Varsha, Hirata Stacy
|
Jan/Feb 1998
Pg. 79-82
|
Amlodipine Besylate 0.5-mg/mL to 10-mg/mL in SuspendIt Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 43
|
Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection
Allen Loyd V Jr
|
May/Jun 2022
Pg. 219-228
|
Amlodipine Besylate 1 mg/mL Veterinary Suspension
Allen Loyd V Jr
|
Sep/Oct 2009
Pg. 429
|
Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases
Mixon William, Helms Scott R
|
Sep/Oct 2008
Pg. 392-397
|
Physicochemical Stability of Compounded Amlodipine Besylate Suspensions in PCCA Base, SuspendIt
Graves Richard A, Mandal Tarun K, Bostanian Levon A, Nguyen Anh TQ, Swopes Demikka, Morris Tommy C, Pramar Yashoda V
|
Nov/Dec 2019
Pg. 519-527
|
Sterile Basics of Compounding: Allowable Endotoxin Levels in Parenteral Preparations
Allen Loyd V Jr
|
Nov/Dec 2023
Pg. 483-486
|
Chlorpromazine Hydrochloride 25-mg/mL Injection, Preserved
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 507
|
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations
Ashe Krystina, Baskett Dustin
|
Sep/Oct 2018
Pg. 387-398
|
Basics of Sterile Compounding: Vehicles Used in Sterile Compounding
Allen Loyd V Jr
|
May/Jun 2019
Pg. 221-228
|
Cyclobenzaprine 5-mg/g and Guaifenesin 10-mg/g Transdermal Cream
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 313
|
Sterile Basics: Intravenous Admixture Compounding, Part 2: Parenteral Vehicle Considerations
Allen Loyd V Jr
|
May/Jun 2023
Pg. 223-229
|
Overview of Chapter <797> "Pharmaceutical Compounding - Sterile Preparations": The Potential Impact for Compounding Pharmacists
Rahe Hank
|
Mar/Apr 2004
Pg. 89-94
|
Jet Injection Devices for the Needle-free Administration of Compounds, Vaccines, and Other Agents
Logomasini Mark A, Stout Richard R, Ron Marcinkoski
|
Jul/Aug 2013
Pg. 270-280
|
Rocuronium Bromide 10-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 147
|
Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 131-139
|
Basics of Compounding Sterile Preparations: Nomenclature and Considerations
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 313-317
|
| Return to Top |
